These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8448584)

  • 1. Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats.
    Harding P; Stonier C; Aber GM
    Br J Pharmacol; 1993 Feb; 108(2):327-30. PubMed ID: 8448584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
    Harding P; Stonier C; Aber GM
    Clin Sci (Lond); 1991 Oct; 81(4):491-7. PubMed ID: 1657495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress and glomerular prostanoid production: influence of angiotensin converting enzyme inhibition.
    Clayton L; Hiley C; D'Souza RJ; Jones PW; Davies SJ; Strange RC; Aber GM
    Free Radic Res Commun; 1993; 18(2):107-13. PubMed ID: 8386683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin converting enzyme inhibitors on isolated glomeruli.
    Aber GM; Harding P; Stonier C; Messenger A
    J Hypertens Suppl; 1989 Sep; 7(7):S15-9; discussion S19-20. PubMed ID: 2559169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE-inhibitor influence on rat glomerular prostaglandin-synthesis.
    Stetina Z; Weiss K; Sinzinger H
    Prog Clin Biol Res; 1989; 301():285-8. PubMed ID: 2552462
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
    Rodríguez-García JL; Villa E; Serrano M; Gallardo J; García-Robles R
    Blood Press; 1999; 8(5-6):279-84. PubMed ID: 10803488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion.
    Higueruelo S; Vaquero M; Pastor C; Galimany R; Romero R
    Nephrol Dial Transplant; 1998 Sep; 13(9):2227-33. PubMed ID: 9761501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glomerular prostaglandins: synthesis, mechanism of action and interaction with ACE inhibitors].
    Stetina Z
    Wien Klin Wochenschr; 1991; 103(2):51-3. PubMed ID: 1850940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.
    Derad I; Otterbein A; Mölle M; Pietrowsky R; Born J; Fehm HL
    J Hypertens; 1996 Nov; 14(11):1309-15. PubMed ID: 8934359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax.
    Kma L; Gao F; Fish BL; Moulder JE; Jacobs ER; Medhora M
    J Radiat Res; 2012; 53(1):10-7. PubMed ID: 22302041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ; Akarawut W; Smith DE
    Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
    Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
    Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.